Sort
39,280 grants matching “leukemia”
Cancer Center Support Grant (CCSG)
$2,440,011George J Weiner · University Of Iowa · P30 · FY2016 · CA
SPORE: Targeted Therapies for Glioma
$2,438,174Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2019 · CA
Brain Tumor Therapeutic Efficacy by Quantitative MR
$2,437,189Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2008 · CA
COBRE: Center for Computational Biology of Human Disease
$2,436,336David M Rand · Brown University · P20 · FY2016 · GM
THERAPY OF AML
$2,435,347University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
University of Texas M.D. Anderson Cancer SPORE-Leukemia
$2,433,679Jean-Pierre J Issa · University Of Tx Md Anderson Can Ctr · P50 · FY2006 · CA
COG NCTN Year 10 BIQSFP Supplement & Progress Report
$2,432,383Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,431,199Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2021 · CA
Studies of Populations Exposed to Environmental Sources of Radiation
$2,428,038Alina Brenner · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Cancer and Leukemia Group B Statistical Center
$2,427,760Stephen L George · Duke University · U10 · FY2010 · CA
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,421,905James L Riley · University Of Pennsylvania · U19 · FY2023 · AI
Studies of Populations Exposed to Environmental Sources of Radiation
$2,420,882Martha S Linet · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Studies of Occupational Cancer (Pesticides)
$2,417,725Michael Alavanja · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Whole Genome Association Analysis of Hematopoietic Cell Transplant (HCT) Outcome
$2,417,140John Andrew Hansen · Fred Hutchinson Cancer Research Center · R01 · FY2012 · HL
Multiscale Systems to Elucidate Susceptibility and Cardioprotective Mechanisms in Cardio-oncology
$2,415,648Joseph C Wu · Stanford University · P01 · FY2024 · HL
Genetic variation and regulatory networks: Mechanisms and complexity
$2,415,000Dana Pe'er · Columbia Univ New York Morningside · DP2 · FY2007 · OD
Transcriptional Regulation of Cell Growth
$2,411,844Salk Institute For Biological Studies · P01 · FY2003 · CA
Development of Novel Therapeutic Strategies in Human Leukemias
$2,408,966James D Griffin · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$2,408,401Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
THE THERAPY OF AML
$2,404,845Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
THE THERAPY OF AML
$2,401,083Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
Brain Tumor Therapeutic Efficacy of Quantitative MR
$2,400,984Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2011 · CA
ROLE OF RNA SEQUESTRATION IN ACUTE MYELOID LEUKEMIA
$2,398,360Bruno Di Stefano · Baylor College Of Medicine · R01 · FY2025 · CA
Women's Health Initiative Cancer Survivor Cohort
$2,396,733Garnet L. Anderson · Fred Hutchinson Cancer Research Center · UM1 · FY2016 · CA
Identifying small molecules with therapeutic effects in RELAFus -driven EPN, mand testing them in preclinical genetically engineered models of EPN
$2,394,581Kevan M. Shokat · Fred Hutchinson Cancer Research Center · U54 · FY2019 · CA